Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Anti-tumor Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Anti-tumor Drug market. Detailed analysis of key players, along with key growth strategies adopted by Anti-tumor Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Roche
Celgene
Novartis
By Type:
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
By End-User:
Hospital Use
Clinic Use
Household
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-tumor Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Anti-tumor Drug Market Size and Growth Rate of Surgical from 2016 to 2027
-
1.3.2 China Anti-tumor Drug Market Size and Growth Rate of Chemotherapy from 2016 to 2027
-
1.3.3 China Anti-tumor Drug Market Size and Growth Rate of Radiation from 2016 to 2027
-
1.3.4 China Anti-tumor Drug Market Size and Growth Rate of Targeted from 2016 to 2027
-
1.3.5 China Anti-tumor Drug Market Size and Growth Rate of Immunotherapy from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Anti-tumor Drug Market Size and Growth Rate of Hospital Use from 2016 to 2027
-
1.4.2 China Anti-tumor Drug Market Size and Growth Rate of Clinic Use from 2016 to 2027
-
1.4.3 China Anti-tumor Drug Market Size and Growth Rate of Household from 2016 to 2027
-
1.4.4 China Anti-tumor Drug Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anti-tumor Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-tumor Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Surgical
-
3.4.2 Market Size and Growth Rate of Chemotherapy
-
3.4.3 Market Size and Growth Rate of Radiation
-
3.4.4 Market Size and Growth Rate of Targeted
-
3.4.5 Market Size and Growth Rate of Immunotherapy
4 Segmentation of Anti-tumor Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-tumor Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anti-tumor Drug in Hospital Use
-
4.4.2 Market Size and Growth Rate of Anti-tumor Drug in Clinic Use
-
4.4.3 Market Size and Growth Rate of Anti-tumor Drug in Household
-
4.4.4 Market Size and Growth Rate of Anti-tumor Drug in Other
5 Market Analysis by Regions
-
5.1 China Anti-tumor Drug Production Analysis by Regions
-
5.2 China Anti-tumor Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Anti-tumor Drug Landscape Analysis
-
6.1 North China Anti-tumor Drug Landscape Analysis by Major Types
-
6.2 North China Anti-tumor Drug Landscape Analysis by Major End-Users
7 Central China Anti-tumor Drug Landscape Analysis
-
7.1 Central China Anti-tumor Drug Landscape Analysis by Major Types
-
7.2 Central China Anti-tumor Drug Landscape Analysis by Major End-Users
8 South China Anti-tumor Drug Landscape Analysis
-
8.1 South China Anti-tumor Drug Landscape Analysis by Major Types
-
8.2 South China Anti-tumor Drug Landscape Analysis by Major End-Users
9 East China Anti-tumor Drug Landscape Analysis
-
9.1 East China Anti-tumor Drug Landscape Analysis by Major Types
-
9.2 East China Anti-tumor Drug Landscape Analysis by Major End-Users
10 Northeast China Anti-tumor Drug Landscape Analysis
-
10.1 Northeast China Anti-tumor Drug Landscape Analysis by Major Types
-
10.2 Northeast China Anti-tumor Drug Landscape Analysis by Major End-Users
11 Southwest China Anti-tumor Drug Landscape Analysis
-
11.1 Southwest China Anti-tumor Drug Landscape Analysis by Major Types
-
11.2 Southwest China Anti-tumor Drug Landscape Analysis by Major End-Users
12 Northwest China Anti-tumor Drug Landscape Analysis
-
12.1 Northwest China Anti-tumor Drug Landscape Analysis by Major Types
-
12.2 Northwest China Anti-tumor Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Roche
-
13.1.1 Roche Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Celgene
-
13.2.1 Celgene Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Novartis
-
13.3.1 Novartis Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Surgical from 2016 to 2027
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Chemotherapy from 2016 to 2027
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Radiation from 2016 to 2027
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Targeted from 2016 to 2027
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Immunotherapy from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Hospital Use from 2016 to 2027
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Clinic Use from 2016 to 2027
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Household from 2016 to 2027
-
Figure China Anti-tumor Drug Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Anti-tumor Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anti-tumor Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anti-tumor Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-tumor Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Anti-tumor Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Surgical
-
Figure Market Size and Growth Rate of Chemotherapy
-
Figure Market Size and Growth Rate of Radiation
-
Figure Market Size and Growth Rate of Targeted
-
Figure Market Size and Growth Rate of Immunotherapy
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anti-tumor Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anti-tumor Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Use
-
Figure Market Size and Growth Rate of Clinic Use
-
Figure Market Size and Growth Rate of Household
-
Figure Market Size and Growth Rate of Other
-
Table China Anti-tumor Drug Production by Regions
-
Table China Anti-tumor Drug Production Share by Regions
-
Figure China Anti-tumor Drug Production Share by Regions in 2016
-
Figure China Anti-tumor Drug Production Share by Regions in 2021
-
Figure China Anti-tumor Drug Production Share by Regions in 2027
-
Table China Anti-tumor Drug Consumption by Regions
-
Table China Anti-tumor Drug Consumption Share by Regions
-
Figure China Anti-tumor Drug Consumption Share by Regions in 2016
-
Figure China Anti-tumor Drug Consumption Share by Regions in 2021
-
Figure China Anti-tumor Drug Consumption Share by Regions in 2027
-
Table North China Anti-tumor Drug Consumption by Types from 2016 to 2027
-
Table North China Anti-tumor Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Anti-tumor Drug Consumption Share by Types in 2016
-
Figure North China Anti-tumor Drug Consumption Share by Types in 2021
-
Figure North China Anti-tumor Drug Consumption Share by Types in 2027
-
Table North China Anti-tumor Drug Consumption by End-Users from 2016 to 2027
-
Table North China Anti-tumor Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Anti-tumor Drug Consumption Share by End-Users in 2016
-
Figure North China Anti-tumor Drug Consumption Share by End-Users in 2021
-
Figure North China Anti-tumor Drug Consumption Share by End-Users in 2027
-
Table Central China Anti-tumor Drug Consumption by Types from 2016 to 2027
-
Table Central China Anti-tumor Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Anti-tumor Drug Consumption Share by Types in 2016
-
Figure Central China Anti-tumor Drug Consumption Share by Types in 2021
-
Figure Central China Anti-tumor Drug Consumption Share by Types in 2027
-
Table Central China Anti-tumor Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Anti-tumor Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Anti-tumor Drug Consumption Share by End-Users in 2016
-
Figure Central China Anti-tumor Drug Consumption Share by End-Users in 2021
-
Figure Central China Anti-tumor Drug Consumption Share by End-Users in 2027
-
Table South China Anti-tumor Drug Consumption by Types from 2016 to 2027
-
Table South China Anti-tumor Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Anti-tumor Drug Consumption Share by Types in 2016
-
Figure South China Anti-tumor Drug Consumption Share by Types in 2021
-
Figure South China Anti-tumor Drug Consumption Share by Types in 2027
-
Table South China Anti-tumor Drug Consumption by End-Users from 2016 to 2027
-
Table South China Anti-tumor Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Anti-tumor Drug Consumption Share by End-Users in 2016
-
Figure South China Anti-tumor Drug Consumption Share by End-Users in 2021
-
Figure South China Anti-tumor Drug Consumption Share by End-Users in 2027
-
Table East China Anti-tumor Drug Consumption by Types from 2016 to 2027
-
Table East China Anti-tumor Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Anti-tumor Drug Consumption Share by Types in 2016
-
Figure East China Anti-tumor Drug Consumption Share by Types in 2021
-
Figure East China Anti-tumor Drug Consumption Share by Types in 2027
-
Table East China Anti-tumor Drug Consumption by End-Users from 2016 to 2027
-
Table East China Anti-tumor Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Anti-tumor Drug Consumption Share by End-Users in 2016
-
Figure East China Anti-tumor Drug Consumption Share by End-Users in 2021
-
Figure East China Anti-tumor Drug Consumption Share by End-Users in 2027
-
Table Northeast China Anti-tumor Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Anti-tumor Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Anti-tumor Drug Consumption Share by Types in 2016
-
Figure Northeast China Anti-tumor Drug Consumption Share by Types in 2021
-
Figure Northeast China Anti-tumor Drug Consumption Share by Types in 2027
-
Table Northeast China Anti-tumor Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Anti-tumor Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Anti-tumor Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Anti-tumor Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Anti-tumor Drug Consumption Share by End-Users in 2027
-
Table Southwest China Anti-tumor Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Anti-tumor Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Anti-tumor Drug Consumption Share by Types in 2016
-
Figure Southwest China Anti-tumor Drug Consumption Share by Types in 2021
-
Figure Southwest China Anti-tumor Drug Consumption Share by Types in 2027
-
Table Southwest China Anti-tumor Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Anti-tumor Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Anti-tumor Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Anti-tumor Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Anti-tumor Drug Consumption Share by End-Users in 2027
-
Table Northwest China Anti-tumor Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Anti-tumor Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Anti-tumor Drug Consumption Share by Types in 2016
-
Figure Northwest China Anti-tumor Drug Consumption Share by Types in 2021
-
Figure Northwest China Anti-tumor Drug Consumption Share by Types in 2027
-
Table Northwest China Anti-tumor Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Anti-tumor Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Anti-tumor Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Anti-tumor Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Anti-tumor Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Celgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
-
Figure Sales and Growth Rate Analysis of Celgene
-
Figure Revenue and Market Share Analysis of Celgene
-
Table Product and Service Introduction of Celgene
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
